Background Xen is a device for minimally invasive glaucoma surgery, and is used to treat
POAG, pseudoexfoliative or pigmentary glaucoma, as well as refractory glaucoma. The …

Purpose To evaluate the 3‐year treatment outcomes of XEN 45 gel stent in open‐angle
glaucoma patients. Methods In this prospective, single‐centre interventional study …

Abstract Purpose The XEN45 Gel Stent is currently the only FDA-approved sub-conjunctival
minimally invasive glaucoma surgery (MIGS) procedure. It has been used worldwide either …

Purpose To report preliminary 6-month results on the use of the Preserflo Microshunt implant
with and without Ologen in 50 pseudophakic eyes with moderate to advanced primary open …

PURPOSE To present the effectiveness, risk factors for surgical failure, and adverse events
over 12 months in a consecutive diverse cohort of glaucoma patients who underwent solo or …

Purpose To compare safety, effectiveness, and baseline predictors of failure in standalone
primary Xen45 gel stent (Xen) versus trabeculectomy (Trab) in glaucoma. Design …

Background. The purpose of this study is to estimate the incidence of choroidal detachment
(CD) after XEN gel stent implant surgery and to evaluate the associated factors. Methods …

Purpose: To determine the early predictors of surgical success 6 months after XEN surgery
among clinical parameters, including anterior segment optical coherence tomography (AS …

Abstract Background The XEN45 Gel Stent is a subconjunctival filtering device that has
demonstrated promising efficacy. This meta-analysis quantitatively evaluates reported …

ABSTRACT Introduction The XEN Gel, a hydrophilic tube meticulously crafted to adhere to
the principles of the Hagen–Poiseuille law, is designed to facilitate efficient aqueous …